AGL Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of AGL Antibodies for research focused on understanding AGL protein functions. Monoclonal AGL Antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AGL protein, also known as amylo-1,6-glucosidase, plays a crucial role in carbohydrate metabolism by catalyzing the hydrolysis of alpha-1,6-glucosidic linkages in glycogen and amylopectin. The function of AGL is vital for maintaining glucose homeostasis and energy balance in cells. Dysregulation of AGL can lead to metabolic disorders, making it a significant target for research in diabetes and other related conditions. Understanding AGL's role in metabolism can provide valuable insights into potential therapeutic strategies for metabolic diseases. Research utilizing AGL monoclonal antibodies contributes to expanding knowledge about glycogen storage disorders and their treatments. Ongoing studies with AGL monoclonal antibodies continue to reveal new aspects of carbohydrate metabolism regulation. Santa Cruz Biotechnology monoclonal AGL antibodies enable researchers worldwide to advance scientific understanding of metabolic pathways and disease mechanisms.